Ivermectin has been widely mischaracterized and suppressed despite its powerful health benefits. This affordable and well-researched medication has shown remarkable potential for supporting those with autoimmune conditions, respiratory infections, and even certain cancers. During the COVID-19 pandemic, it gained attention for its antiviral properties, yet mainstream media and regulatory agencies actively suppressed its use. Why? Because acknowledging ivermectin’s efficacy could have threatened the financial success of more lucrative pharmaceutical treatments.